State Street Corp Recursion Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 12,870,272 shares of RXRX stock, worth $88.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,870,272

Previous 8,749,587 47.1%

Holding current value

$88.9 Million

Previous $65.6 Million 29.25%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.92 - $8.6 $24.4 Million - $35.4 Million	4,120,685 Added 47.1%	12,870,272 $84.8 Million
Q2 2024 Aug 14, 2024	SELL	$7.35 - $10.05 $11.8 Million - $16.1 Million	-1,602,769 Reduced 15.48%	8,749,587 $65.6 Million
Q1 2024 May 15, 2024	SELL	$9.13 - $15.52 $16.4 Million - $27.9 Million	-1,799,290 Reduced 14.81%	10,352,356 $103 Million
Q4 2023 Feb 14, 2024	BUY	$5.09 - $10.79 $2.01 Million - $4.26 Million	394,558 Added 3.36%	12,151,646 $120 Million
Q3 2023 Nov 14, 2023	BUY	$6.59 - $15.86 $39.9 Million - $96.1 Million	6,059,156 Added 106.34%	11,757,088 $89.9 Million
Q2 2023 Aug 14, 2023	SELL	$4.56 - $9.94 $3.08 Million - $6.71 Million	-674,583 Reduced 10.59%	5,697,932 $42.6 Million
Q1 2023 May 15, 2023	SELL	$6.42 - $9.64 $9.62 Million - $14.4 Million	-1,498,443 Reduced 19.04%	6,372,515 $42.5 Million
Q4 2022 Feb 14, 2023	BUY	$7.16 - $12.7 $23.7 Million - $42.1 Million	3,315,199 Added 72.77%	7,870,958 $60.7 Million
Q3 2022 Nov 15, 2022	BUY	$7.83 - $13.6 $19 Million - $33 Million	2,430,027 Added 114.31%	4,555,759 $48.5 Million
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.26 $1.04 Million - $1.92 Million	206,998 Added 10.79%	2,125,732 $17.3 Million
Q1 2022 May 16, 2022	SELL	$6.16 - $18.03 $16.9 Million - $49.4 Million	-2,737,993 Reduced 58.8%	1,918,734 $13.7 Million
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $48.6 Million - $65.8 Million	3,012,233 Added 183.17%	4,656,727 $79.8 Million
Q3 2021 Nov 15, 2021	BUY	$19.03 - $41.33 $24.1 Million - $52.4 Million	1,267,062 Added 335.71%	1,644,494 $37.8 Million
Q2 2021 Aug 16, 2021	BUY	$18.0 - $37.42 $6.79 Million - $14.1 Million	377,432 New	377,432 $13.8 Million

Others Institutions Holding RXRX

# of Institutions

286

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.25B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Recursion Pharmaceuticals, Inc. Transaction History